Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 38% of the global population, with ...

Under the terms of the agreement and subject to certain conditions, Teva will pay Samsung Bioepis an upfront payment over the next 3 years. Samsung Bioepis may be eligible for additional launch and ...

QTORIN™ rapamycin could become the first FDA-approved therapy for microcystic lymphatic malformations, a serious, lifelong rare disease affecting an estimated more than 30,000 diagnosed children and ...

Only 27% of dog owners in two studies gave medication at the right intervals; Convenia RTU is expected to be available to veterinarians in Q1 2027.

20 scientific presentations underscore the breadth of AbbVie's leadership in Inflammatory Bowel Disease (IBD) research programs Latest long-term and real-world data with SKYRIZI ® (risankizumab) and ...

The EQ Press is a dynamic compression device that helps improve lymphatic flow by filling with air in sequential chambers to push fluid from the coronary band up the leg. In this episode of the ...

The Nature Index 2026 Research Leaders reveal the leading institutions and countries/territories in the natural sciences, health sciences, applied sciences and social sciences, according to their ...

Desmoid tumors (DTs) are rare fibroblastic neoplasms driven by altered Wnt signaling pathways, through activating mutations in β-catenin (CTNNB1) or loss of repressive APC. DTs are considered as ...

• Growing evidence shows that shorter courses of antibiotics are just as effective as longer regimens for many common infections, while helping reduce antimicrobial resistance. • National and ...

Stage 4 papillary thyroid cancer involves distant metastasis, with treatment focusing on disease control and quality of life rather than cure. Diagnostic tools include imaging, biopsy, and molecular ...